Stock Price
285.03
Daily Change
-0.72 -0.25%
Monthly
12.26%
Yearly
45.48%
Q4 Forecast
279.32

EPS Reference Time Actual Consensus Previous
2026-10-13 FY2026Q3 AM 2.59 3.03 2.80
2026-07-15 FY2026Q2 AM 2.90 2.85 2.77
2026-04-14 FY2026Q1 AM 2.70 2.69 2.77
2026-01-21 FY2025Q4 AM 2.46 2.53 2.04
2025-10-14 FY2025Q3 AM 2.80 2.75 2.42



Peers Price Chg Day Year Date
AbbVie 297.84 2.81 0.95% 27.28% Nov/16
Abbott 108.69 0.17 0.16% -16.77% Nov/16
Amgen 469.64 3.97 0.85% 37.44% Nov/16
AstraZeneca 14,068.00 86.00 0.62% 3.50% Nov/16
Baxter International 25.74 -0.07 -0.27% 39.36% Nov/16
Bayer 57.04 0.52 0.92% 104.12% Nov/16
Becton, Dickinson and Co. 217.52 -0.51 -0.23% 12.68% Nov/16
Biogen 253.40 2.92 1.17% 51.24% Nov/13
Bristol-Myers Squibb 63.11 -0.32 -0.50% 35.28% Nov/16
Boston Scientific 44.22 -0.12 -0.27% -56.94% Nov/16

Indexes Price Day Year Date
US Index 500 7483 -78.96 -1.04% 12.14% Nov/16
US Index 30 52028 -319.75 -0.61% 11.67% Nov/16

Johnson & Johnson traded at $285.55 this Monday November 16th, decreasing $0.20 or 0.07 percent since the previous trading session. Looking back, over the last four weeks, J&J lost 12.46 percent. Over the last 12 months, its price rose by 45.74 percent. Looking ahead, we forecast Johnson & Johnson to be priced at 279.32 by the end of this quarter and at 260.89 in one year, according to Trading Economics global macro models projections and analysts expectations.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.



News Stream
J&J Stock Price Hits 4-week Low
J&J shares decreased to 263.02 USD, the lowest since August 2026. Over the past 4 weeks, Johnson & Johnson gained 0.39%, and in the last 12 months, it increased 48.47%.
2026-09-15
J&J Stock Price Hits All-time High
J&J shares increased to an all-time high of 276.52 USD. Over the past 4 weeks, Johnson & Johnson gained 8.6%, and in the last 12 months, it increased 55.16%.
2026-09-02
J&J Stock Price Hits All-time High
J&J shares increased to an all-time high of 251.76 USD. Over the past 4 weeks, Johnson & Johnson gained 9.14%, and in the last 12 months, it increased 65.27%.
2026-06-26